Surveying the features of screening strategies for non-alcoholic fatty liver disease: A scoping review.

Nazanin Mir, Hamid R Baradaran, Seidamir Pasha Tabaeian, Nasrin Abolhasanbeigi Gallehzan, Aziz Rezapour

Abstract readReview

In one paragraph

Review in Journal of education and health promotion, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nazanin MirHealth Management and Economics Research Center, Health Management Research Institute, Iran University of Medical Sciences, Tehran, Iran.

Hamid R BaradaranEpidemiology, Endocrine Research Center, Institute of Endocrinology and Metabolism, University of Medical Sciences, Tehran, Iran.

Seidamir Pasha TabaeianGastroenterology and Hepatology, Colorectal Research Center, Iran University of Medical Sciences, Tehran, Iran.

Nasrin Abolhasanbeigi GallehzanHealth Management and Economics Research Center, Health Management Research Institute, Iran University of Medical Sciences, Tehran, Iran.

Aziz RezapourHealth Economics, Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, affecting about one-quarter of the general population worldwide. Owing to the prevalence and high burden of NAFLD in special groups, this study aimed to examine the features of screening strategies for NAFLD in special populations. We carried out a scoping review using the main online databases (Medline (PubMed), Scopus, and Web of Science) with the following keywords: Screening, Nonalcoholic fatty liver, willingness to pay, economic evaluation, and preferences. We included publications from January 1, 2000, to August 27, 2024, which focused on NAFLD screening strategies in special populations. Quality assessment of the included studies was performed using the QADAS checklist. The AUC ranged from 0.5 to 93.30, the maximum value corresponding to the WC test in the MAFLD population. The highest sensitivity and specificity were related to the BMI test (96.89) and the BRI test in the T

Indexed as

Contingent valuation methodnon-alcoholic fatty liverscreeningwillingness to pay

Identifiers

PMID42016413

DOI10.4103/jehp.jehp_169_25

PMCPMC13094901

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC-ND

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.